Photo of David Goldberg

David Goldberg

Professor

  • 70 Cowcaddens Road, Glasgow Caledonian University

    G4 0BA Glasgow

    United Kingdom

20052019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where David Goldberg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles
Hepacivirus Medicine & Life Sciences
Scotland Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Drug Users Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences
Infection Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

Hepacivirus
Population
Scotland
Pharmaceutical Preparations
Homeless Persons
2 Downloads (Pure)

Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)

Hickman, M., Dillon, J. F., Elliott, L., De Angelis, D., Vickerman, P., Foster, G., Donnan, P., Eriksen, A., Flowers, P., Goldberg, D., Hollingworth, W., Ijaz, S., Liddell, D., Mandal, S., Martin, N., Beer, L. J. Z., Drysdale, K., Fraser, H., Glass, R., Graham, L. & 29 others, Gunson, R. N., Hamilton, E., Harris, H., Harris, M., Harris, R., Heinsbroek, E., Hope, V., Horwood, J., Inglis, S. K., Innes, H., Lane, A., Meadows, J., McAuley, A., Metcalfe, C., Migchelsen, S., Murray, A., Myring, G., Palmateer, N., Presanis, A., Radley, A., Ramsay, M., Samartsidis, P., Simmons, R., Sinka, K., Vojt, G., Ward, Z., Whiteley, D., Yeung, A. & Hutchinson, S. J., 24 Sep 2019, In : BMJ Open. 9, 9, 12 p.

Research output: Contribution to journalArticle

Open Access
File
Hepatitis C
Hepacivirus
Antiviral Agents
Pharmaceutical Preparations
Population
17 Downloads (Pure)

Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO Member State responses 2017

Smith, S., Harmanci, H., Hutin, Y., Hess, S., Bulterys, M., Peck, R., Rewari, B., Mozalevskis, A., Shibeshi, M., Mumba, M., Le, L-V., Ishikawa, N., Nolna, D., Sereno, L., Gore, C., Goldberg, D. & Hutchinson, S., Aug 2019, In : Journal of Hepatology Reports. 1, 2, p. 81-89 9 p.

Research output: Contribution to journalArticle

Open Access
File
Hepatitis
Public Health
Hepatitis B virus
Hepatitis C
Viruses

Real‐world impact following initiation of interferon‐free hepatitis C regimens on liver‐related outcomes and all‐cause mortality among patients with compensated cirrhosis

McDonald, S. A., Pollock, K. G., Barclay, S. T., Goldberg, D. J., Bathgate, A., Bramley, P., Dillon, J. F., Fraser, A., Innes, H. A., Kennedy, N., Morris, J., Went, A., Hayes, P. C. & Hutchinson, S. J., 6 Nov 2019, In : Journal of Viral Hepatitis. 11 p.

Research output: Contribution to journalArticle

Hepatitis C
Fibrosis
Mortality
Liver
Antiviral Agents
16 Downloads (Pure)

Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis

McAuley, A., Palmateer, N. E., Goldberg, D. J., Trayner, K. M. A., Shepherd, S. J., Gunson, R. N., Metcalfe, R., Milosevic, C., Taylor, A., Munro, A. & Hutchinson, S. J., May 2019, In : The Lancet HIV. 6, 5, p. e315-e324

Research output: Contribution to journalArticle

Open Access
File
Harm Reduction
Cross-Sectional Studies
HIV
HIV Infections
Disease Outbreaks